Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome in Canada: Analysis of data from the Canadian Nosocomial Infection Surveillance Program.
Amro QaddouraJessica BartoszkoRobyn MitchellCharles FrenetteLynn JohnstonDominik MertzLinda PeludeNisha ThampiStephanie W SmithPublished in: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada (2024)
Our findings suggest that critically ill patients in Canadian hospitals who received ECMO had different characteristics from those who did not receive ECMO. We also observed a trend of decreased mortality over the waves for the ECMO group. Possible explanatory factors may include potential delay in ECMO initiation during Wave 1, evolution of the virus, better understanding of COVID-19 disease and ECMO use, and new medical treatments and vaccines available in later waves. These findings may provide insight for future potential pandemics.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- mechanical ventilation
- coronavirus disease
- sars cov
- respiratory failure
- healthcare
- public health
- type diabetes
- electronic health record
- staphylococcus aureus
- intensive care unit
- cardiovascular events
- quality improvement
- risk factors
- risk assessment
- human health
- coronary artery disease
- machine learning
- methicillin resistant staphylococcus aureus
- deep learning
- respiratory syndrome coronavirus